2026-07-02
No AI summary for this filing type
View Full Filing (SEC EDGAR)Unicycive Therapeutics INC
+$21.5M
Net Activity
Institutions Holding
51
Popularity Rank
#5947
Avg Weight
0.09%
Total Value
$68.3M
51 institutions currently hold UNCY, with 28 net buyers and 12 net sellers this quarter.
Institutional Moves (Q1 2026)
Majority Increased
Based on recent trading activity
Net Selling Institutions
12
Net Buying Institutions
28
Top 5 by Value
+$28.0M
Total Buy Value
$3.2M
Total Sell Value
28
Net Buyers
12
Net Sellers
1
Filings (90d)
$9.45M
Total Est. Value
1.79M shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 2026-07-01 | $9.45M |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
0
Active 5%+ Holders
| Reporting Person | Type | Filing Date | % of Class |
|---|---|---|---|
| Integrated Core Strategies (US) LLC | 13G/A | 2026-07-08 | 1.0% |
1
Filings (14d)
No AI summary for this filing type
View Full Filing (SEC EDGAR)The most-added stocks by 13F institutions this quarter
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter